Literature DB >> 11739686

Cyclin T1 expression is mediated by a complex and constitutively active promoter and does not limit human immunodeficiency virus type 1 Tat function in unstimulated primary lymphocytes.

Juan Martin-Serrano1, Kelvin Li, Paul D Bieniasz.   

Abstract

Cyclin T1 (CycT1), a component of positive-transcription-elongation factor-b (P-TEFb), is an essential cofactor for transcriptional activation by lentivirus Tat proteins. It is thought that low CycT1 expression levels restrict human immunodeficiency virus type 1 (HIV-1) expression levels and replication in resting CD4+ lymphocytes. In this study, we undertook a functional analysis of the cycT1 promoter to determine which, if any, promoter elements might be responsible for cellular activation state-dependent CycT1 expression. The cycT1 gene contains a complex promoter that exhibits an extreme degree of functional redundancy: five nonoverlapping fragments were found to exhibit significant promoter activity in immortalized cell lines, and these elements could interact in a synergistic or redundant manner to mediate cycT1 transcription. Reporter gene expression, mediated by the cycT1 promoter, was detectable in unstimulated transfected primary lymphocytes and multiple sites within the promoter could serve to initiate transcription. While utilization of these start sites was significantly altered by the application of exogenous stimuli to primary lymphocytes and two distinct promoter elements exhibited enhanced activity in the presence of phorbol ester, overall cycT1 transcription was only modestly enhanced in response to cell activation. These observations prompted a reexamination of CycT1 protein expression in primary lymphocytes. In fact, steady-state CycT1 expression is only slightly lower in unstimulated lymphocytes compared to phorbol ester-treated cells or a panel of immortalized cell lines. Importantly, CycT1 is expressed at sufficient levels in unstimulated primary cells to support robust Tat activity. These results strongly suggest that CycT1 expression levels in unstimulated primary lymphocytes do not profoundly limit HIV-1 gene expression or provide an adequate mechanistic explanation for proviral latency in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11739686      PMCID: PMC135689          DOI: 10.1128/jvi.76.1.208-219.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

Review 1.  CpG islands as genomic footprints of promoters that are associated with replication origins.

Authors:  F Antequera; A Bird
Journal:  Curr Biol       Date:  1999-09-09       Impact factor: 10.834

2.  Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase.

Authors:  N F Marshall; J Peng; Z Xie; D H Price
Journal:  J Biol Chem       Date:  1996-10-25       Impact factor: 5.157

Review 3.  Reversible phosphorylation of the C-terminal domain of RNA polymerase II.

Authors:  M E Dahmus
Journal:  J Biol Chem       Date:  1996-08-09       Impact factor: 5.157

4.  The kappaB sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth.

Authors:  B K Chen; M B Feinberg; D Baltimore
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells.

Authors:  S Kinoshita; L Su; M Amano; L A Timmerman; H Kaneshima; G P Nolan
Journal:  Immunity       Date:  1997-03       Impact factor: 31.745

6.  Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor.

Authors:  C H Herrmann; A P Rice
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

7.  HIV-1 latency due to the site of proviral integration.

Authors:  B J Winslow; R J Pomerantz; O Bagasra; D Trono
Journal:  Virology       Date:  1993-10       Impact factor: 3.616

8.  Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts.

Authors:  M Adams; L Sharmeen; J Kimpton; J M Romeo; J V Garcia; B M Peterlin; M Groudine; M Emerman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

9.  HIV-1 Tat protein promotes formation of more-processive elongation complexes.

Authors:  R A Marciniak; P A Sharp
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

10.  Absolute dependence on kappa B responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes.

Authors:  J Alcamí; T Laín de Lera; L Folgueira; M A Pedraza; J M Jacqué; F Bachelerie; A R Noriega; R T Hay; D Harrich; R B Gaynor
Journal:  EMBO J       Date:  1995-04-03       Impact factor: 11.598

View more
  5 in total

1.  Heterogeneity of Latency Establishment in the Different Human CD4+ T Cell Subsets Stimulated with IL-15.

Authors:  Raffaele De Francesco; Lara Manganaro; Giacomo M Butta; Giorgio Bozzi; Greta Gallo; Gaia Copaloni; Chiara Cordiglieri; Mariacristina Crosti; Marilena Mancino; Daniele Prati; Viviana Simon; Andrea Gori; Alessandra Bandera
Journal:  J Virol       Date:  2022-05-02       Impact factor: 6.549

2.  Optimized chimeras between kinase-inactive mutant Cdk9 and truncated cyclin T1 proteins efficiently inhibit Tat transactivation and human immunodeficiency virus gene expression.

Authors:  Koh Fujinaga; Dan Irwin; Matthias Geyer; B Matija Peterlin
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  A truncated form of Nef selected during pathogenic reversion of simian immunodeficiency virus SIVmac239Deltanef increases viral replication.

Authors:  Lisa A Chakrabarti; Karin J Metzner; Tijana Ivanovic; Hua Cheng; Jean Louis-Virelizier; Ruth I Connor; Cecilia Cheng-Mayer
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 4.  Confronting proviral HIV infection.

Authors:  David M Margolis
Journal:  Curr HIV/AIDS Rep       Date:  2007-05       Impact factor: 5.071

Review 5.  Restrictions to HIV-1 replication in resting CD4+ T lymphocytes.

Authors:  Xiaoyu Pan; Hanna-Mari Baldauf; Oliver T Keppler; Oliver T Fackler
Journal:  Cell Res       Date:  2013-06-04       Impact factor: 25.617

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.